First Header Logo Second Header Logo

Connection

Pierre Triozzi to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Pierre Triozzi has written about Xenograft Model Antitumor Assays.
Pierre Triozzi
Connection Strength
0.102
Xenograft Model Antitumor Assays
  1. Triozzi PL, Aldrich W, Dombos C. Differential effects of imatinib mesylate against uveal melanoma in vitro and in vivo. Melanoma Res. 2008 Dec; 18(6):420-30.
    View in: PubMed
    Score: 0.079
  2. Negrotto S, Hu Z, Alcazar O, Ng KP, Triozzi P, Lindner D, Rini B, Saunthararajah Y. Noncytotoxic differentiation treatment of renal cell cancer. Cancer Res. 2011 Feb 15; 71(4):1431-41.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.